Neuropsychological functioning of children treated with intensive chemotherapy followed by myeloablative consolidation chemotherapy and autologous hematopoietic cell rescue for newly diagnosed CNS tumors: An analysis of the head start II survivors

Pediatric Blood and Cancer

Volumn 54, Issue 3, 2010, Pages 429-436

  Sands, Stephen A ^a   Oberg, Jennifer A ^a   Gardner, Sharon L ^b   Whiteley, Jennifer A ^a   Glade Bender, Julia L ^a   Finlay, Jonathan L ^c  

^a Columbia University College of Physicians and Surgeons ^*  (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Intelligence; Late effects; Neuropsychology; Pediatric brain tumors; Survivorship

Indexed keywords

CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; ETOPOSIDE; METHOTREXATE; TEMOZOLOMIDE; THIOTEPA; VINCRISTINE;

ACADEMIC ACHIEVEMENT; ARTICLE; ASTROCYTOMA; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; BEHAVIOR; BRAIN RADIATION; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVOR; CENTRAL NERVOUS SYSTEM TUMOR; CHILD; CHOROID PLEXUS TUMOR; CLINICAL ARTICLE; CLINICAL EVALUATION; CLINICAL TRIAL; DRUG MEGADOSE; EPENDYMOMA; FEMALE; FOLLOW UP; FUNCTIONAL STATUS; GLIOBLASTOMA; GLIOMA; HUMAN; INTELLIGENCE TEST; INTENSIVE CARE; LANGUAGE; LEARNING; MALE; MEDULLOBLASTOMA; MULTICENTER STUDY; MULTIPLE CYCLE TREATMENT; MYELOABLATIVE CONDITIONING; NEUROLOGIC EXAMINATION; NEUROPSYCHOLOGY; PRESCHOOL CHILD; PRIORITY JOURNAL; PSYCHOLOGIC ASSESSMENT; READING; SCHOOL CHILD; SHORT TERM MEMORY; VERBAL MEMORY; VISUAL MEMORY; VISUOMOTOR COORDINATION;

BRAIN NEOPLASMS; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; CRANIAL IRRADIATION; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INTELLIGENCE; MALE; METHOTREXATE; NEUROPSYCHOLOGICAL TESTS; PSYCHOMOTOR PERFORMANCE; SURVIVORS;

EID: 76749156626     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.22318     Document Type: Article

References (56)

1. Finlay JL, Erdreich-Epstein A, Packer RJ. Progress in the treatment of childhood brain tumors: No room for complacency. Pediatr Hematol Oncol 2007;24:79-84.
2. Packer RJ, Goldwein J, Nicholson HS, et al. Treatment of children with medulloblastomas with reduced-dose craniospinal radiation therapy and adjuvant chemotherapy: A Children's Cancer Group Study. J Clin Oncol 1999;17:2127-2136.
3. ButlerRW, Mulhern RK. Neurocognitive interventions for children and adolescents surviving cancer. J Pediatr Psychol 2005;30: 65-78.
4. Duffner PK. Long-term effects of radiation therapy on cognitive and endocrine function in children with leukemia and brain tumors. Neurologist 2004;10:293-310.
5. Hoppe-Hirsch E, Brunet L, Laroussinie F, et al. Intellectual outcome in children with malignant tumors of the posterior fossa: Influence of the field of irradiation and quality of surgery. Child Nerv Syst 1995;11:340-345.
6. Kiltie AE, Lashford LS, Gattamaneni HR. Survival and late effects in medulloblastoma patients treated with craniospinal irradiation under three years old. Med Pediatr Oncol 1997;28:348-354.
7. Maddrey AM, Bergeron JA, Lombardo ER, et al. Neuropsychological performance and quality of life of 10 year survivors of childhood medulloblastoma. J Neurooncol 2005;72:245-253.
8. Mulhern RK, Butler RW. Neurocognitive sequelae of childhood cancers and their treatment. Pediatr Rehabil 2004;7:1-16.
9. Mulhern RK, Hancock J, Fairclough D, et al. Neuropsychological status of children treated for brain tumors: A critical review and integrative analysis. Med Pediatr Oncol 1992;20:181-191.
10. Mulhern RK, Palmer SL, Merchant TE, et al. Neurocognitive consequences of risk-adapted therapy for childhood medulloblastoma. J Clin Oncol 2005;23:5511-5519.
11. Mulhern RK, Palmer SL, Reddick WE, et al. Risks of young age for selected neurocognitive deficits in medulloblastoma are associated with white matter loss. J Clin Oncol 2001;19:472-479.
12. Palmer SL, Goloubeva O, Reddick WE, et al. Patterns of intellectual development among survivors of pediatric medulloblastoma: A longitudinal analysis. J Clin Oncol 2001;19:2302-2308.
13. Radcliffe J, Bunin GR, Sutton LN, et al. Cognitive deficits in long-term survivors of childhood medulloblastoma and other noncortical tumors: Age-dependent effects of whole brain radiation. Int J Dev Neurosci 1994;12:327-334.
14. Carpentieri SC, Meyer EA, Delaney BL, et al. Psychosocial and behavioral functioning among pediatric brain tumor survivors. J Neurooncol 2003;63:279-287.
15. Fuemmeler BF, Elkin TD, Mullins LL. Survivors of childhood brain tumors: Behavioral, emotional, and social adjustment. Clin Psychol Rev 2002;22:547-585.
16. Vannatta K, Gartstein MA, Short A, et al.Acontrolled study of peer relationships of children surviving brain tumors: Teacher, peer, and self ratings. J Pediatr Psychol 1998;23:279-287.
17. Patenaude AF, Kupst MJ. Psychosocial functioning in pediatric cancer. J Pediatr Psychol 2005;30:9-27.
18. Barrera M, Schulte F, Spiegler B. Factors influencing depressive symptoms of children treated for a brain tumor. J Psychosoc Oncol 2007;26:1-16.
19. Copeland DR, deMoor C, Moore Iii BD, et al. Neurocognitive development of children after a cerebellar tumor in infancy: A longitudinal study. J Clin Oncol 1999;17:3476-3486.
20. Ellenberg L, McComb JG, Siegel SE, et al. Factors affecting intellectual outcome in pediatric brain tumor patients. Neurosurgery 1987;21:638-644.
21. Grill J, Sainte-Rose C, Jouvet A, et al. Treatment of medulloblastoma with postoperative chemotherapy alone: An SFOP prospective trial in young children. Lancet Oncol 2005;6:573-580.
22. Moore BD III, Ater JL, Copeland DR. Improved neuropsychological outcome in children with brain tumors diagnosed during infancy and treated without cranial irradiation. J Child Neurol 1992;7:281-290.
23. Packer R, Sutton L, Atkins T, et al.Aprospective study of cognitive function in children receiving whole brain radiotherapy and chemotherapy: 2-year results. J Neurosurg 1989;70:707-713.
24. Packer RJ, Sposto R, Atkins TE, et al. Quality of life in children with primitive neuroectodermal tumors (medulloblastoma) of the posterior fossa. Pediatr Neurosci 1987;13:169-175.
25. Ater JL, van Eys J, Woo SY, et al. MOPP chemotherapy without irradiation as primary postsurgical therapy for brain tumors in infants and young children. J Neurooncol 1997;32:243-252.
26. Geyer JR, Sposto R, Jennings M, et al. Multiagent chemotherapy and deferred radiotherapy in infants with malignant brain tumors: A Report From the Children's Cancer Group. J Clin Oncol 2005;23:7621-7631.
27. Geyer JR, Zeltzer PM, Boyett JM, et al. Survival of infants with primitive neuroectodermal tumors or malignant ependymomas of the CNS treated with eight drugs in 1 day: A report from the Childrens Cancer Group. J Clin Oncol 1994;12:1607-1615.
28. Rutkowski S, Bode U, Deinlein F, et al. Treatment of early childhood medulloblastoma by postoperative chemotherapy alone. N Engl J Med 2005;352:978-986.
29. White L, Kellie S, Gray E, et al. Postoperative chemotherapy in children less than 4 years of age with malignant brain tumors: Promising Initial Response to a VETOPEC-Based Regimen A Study of the Australian and New Zealand Children's Cancer Study Group (ANZCCSG). J Pediatr Hematol Oncol 1998;20:125-130.
30. Dhall G, Grodman H, Ji L, et al. Outcome of children less than three years old at diagnosis with non-metastatic medulloblastoma treated with chemotherapy on the "Head Start" I and II protocols. Pediatr Blood Cancer 2008;50:1169-1175.
31. Bayley N. Bayley scales of infant development: Second edition-Manual. San Antonio, TX: The Psychological Corporation; 1993.
32. Wechsler D. Wechsler Intelligence Scale for Children - Revised. New York, NY: The Psychological Corporation; 1974.
33. Wechsler D. Manual for the Weschler Intelligence Scale for Children - Revised. New York, NY: The Psychological Corporation; 1989.
34. Wechsler D. Wechsler Intelligence Scale for Children - Third Edition. New York, NY: The Psychological Corporation; 1991.
35. Beery KE. The Visual-Motor Integration Test: Administration, Scoring and Teaching Manual. Austin, TX: Pro-Ed; 1997.
36. Dunn LM, Dunn ES. Peabody picture vocabulary test - III. Circle Pines, MN: American Guidance Service; 1997.
37. Wechsler D. Wechser individual achievement test. San Antonio, TX: The Psychlogical Corporation; 1992.
38. Wechsler D. Wechsler individual achievement test. San Antonio, TX: Psychological Corporation; 2002.
39. Cohen MJ. CMS: Children's memory scale manual. San Antonio: The Psychological Corporation, Harcourt; Brace & Company; 1997.
40. Reynolds CR, Kamphaus RW. BASC: Behavior assessment system for children manual. Circle Pines, MN: American Guidance Service, Inc.; 1998.
41. Achenbach TM, Edelbrock C. Manual for the child behavior checklist and revised child behavior profile. Burlington, VT: University of Vermont; 1981.
42. SPSS, Inc. SPSS Base 15.0 for Windows User's Guide. Chicago, IL: SPSS, Inc.; 2007.
43. Duffner PK, Cohen ME, Thomas PR, et al. The long-term effects of cranial irradiation on the central nervous system. Cancer 1985;56: 1841-1846.
44. Mulhern RK, Merchant TE, Gajjar A, et al. Late neurocognitive sequelae in survivors of brain tumours in childhood. Lancet Oncol 2004;5:399-408.
45. Palmer SL, Gajjar A, Reddick WE, et al. Predicting intellectual outcome among children treated with 35-40 Gy craniospinal irradiation for medulloblastoma. Neuropsychology 2003;17: 548-555.
46. Reimers TS, Ehrenfels S, Mortensen EL, et al. Cognitive deficits in long-term survivors of childhood brain tumors: Identification of predictive factors. Med Pediatr Oncol 2003;40:26-34.
47. Ris MD, Packer R, Goldwein J, et al. Intellectual outcome after reduced-dose radiation therapy plus adjuvant chemotherapy for medulloblastoma: A Children's Cancer Group Study. J Clin Oncol 2001;19:3470-3476.
48. Spiegler BJ, Bouffet E, Greenberg ML, et al. Change in neurocognitive functioning after treatment with cranial radiation in childhood. J Clin Oncol 2004;22:706-713.
49. Anderson VA, Godber T, Smibert E, et al. Cognitive and academic outcome following cranial irradiation and chemotherapy in children: A longitudinal study. Br J Cancer 1999;82:255-262.
50. Fouladi M, Gilger E, Kocak M, et al. Intellectual and functional outcome of children 3 years old or younger who have CNS malignancies. J Clin Oncol 2005;23:7152-7160.
51. Rutkowski S, Gerber NU, von Hoff K, et al. Treatment of early childhood medulloblastoma by postoperative chemotherapy and deferred radiotherapy. Neuro Oncol 2009;11:201-210.
52. Iuvone L, Mariotti P, Colosimo C, et al. Long-term cognitive outcome, brain computed tomography scan, and magnetic resonance imaging in children cured for acute lymphoblastic leukemia. Cancer 2002;95:2562-2570.
53. Montour-Proulx I, Kuehn SM, Keene DL, et al. Cognitive changes in children treated for acute lymphoblastic leukemia with chemotherapy only according to the Pediatric Oncology Group 9605 protocol. J Child Neurol 2005;20:129-133.
54. Moore IM, Miketova P, Hockenberry M, et al. Methotrexate-induced alterations in beta-oxidation correlate with cognitive abilities in children with acute lymphoblastic leukemia. Biol Res Nurs 2008;9:311-319.
55. 2) as central nervous system preventive therapy for childhood acute lymphoblastic leukemia: Results of National Cancer Institute/Children's Cancer Group trials CCG-191P, CCG-134P and CCG-144P. Leuk Lymphoma 2006;47: 2488-2504.
56. Riva D, Giorgi C, Nichelli F, et al. Intrathecal methotrexate affects cognitive function in children with medulloblastoma. Neurology 2002;59:48-53.